Sulforaphane-induced apoptosis involves the type 1 IP3 receptor

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Sulforaphane (SFN) is a natural compound found in cruciferous vegetables with known anti-cancer properties.
• The precise molecular mechanisms underlying SFN's anti-tumor effects are still under investigation.
• Inositol trisphosphate receptors (IP3Rs) are critical regulators of intracellular calcium signaling.

Purpose of the Study:

• To elucidate the role of the type 1 inositol 1,4,5-trisphosphate receptor (IP3R1) in mediating the anti-tumor effects of SFN.
• To investigate the impact of SFN on cellular pathways, including reactive oxygen species (ROS) generation, transcription factor activity, and calcium homeostasis.
• To validate the findings in both in vitro cancer cell models and in vivo animal models.

Main Methods:

• In vitro studies using A2780 ovarian carcinoma cells and other cell lines treated with SFN.
• In vivo studies using nude mice bearing tumors treated with SFN.
• Assessment of ROS generation, gene and protein expression (NRF2, IP3R1, HO-1, NQO1, KLF9, HSP27), and apoptosis.
• Pharmacological inhibition of IP3R1 using Xestospongin C (Xest) and genetic silencing of IP3R1, IP3R2, and IP3R3.
• Analysis of calcium content in the endoplasmic reticulum and nucleus, and IP3R1 localization via immunofluorescence.

Main Results:

• SFN treatment induced mitochondrial ROS generation and upregulated NRF2 and its downstream targets early on, with sustained NRF2 and IP3R1 upregulation later.
• SFN induced apoptosis, which was significantly attenuated by IP3R1 inhibition or silencing, and partially by NRF2 silencing.
• IP3R1 inhibition reversed SFN-induced changes in nuclear and reticular calcium content, and SFN treatment caused IP3R1 nuclear translocation.

Conclusions:

• IP3R1 is a key mediator of SFN's anti-tumor activity, primarily through the modulation of calcium signaling.
• SFN-induced apoptosis involves IP3R1-dependent calcium release from the endoplasmic reticulum and subsequent nuclear calcium increase.
• Targeting IP3R1 may represent a therapeutic strategy to enhance the efficacy of SFN in cancer treatment.